| 1 |
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin, 2007, 57: 43-66.
|
| 2 |
陈创奇，马晋平，卢砺锋，等. 综合措施提高结直肠癌术后患者的随访率[J/CD]. 中华普通外科学文献:电子版, 2010, 4(6): 579-582.
|
| 3 |
Huerta S, Goulet EJ, Livingston EH. Colon cancer and apoptosis. Am J Surg, 2006, 191: 517-526.
|
| 4 |
Rupnarain C, Dlamini Z, Naicker S, et al. Colon Cancer: genomics and apoptotic events. Biol Chem, 2004, 385(6): 449-464.
|
| 5 |
Watson AJ. An overview of apoptosis and the prevention of colorectal cancer. Crit Rev Oncol Hematol, 2006, 57(2): 107-121.
|
| 6 |
Lin JH, Deng G, Huang Q, et al. KIAP, a novel member of the inhibitor of apoptosis protein family. Biochem Biophys Res Commun, 2000, 279(3): 820-831.
|
| 7 |
Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res, 2002, 30: e36.
|
| 8 |
Kawasaki H, Toyoda M, Shinohara H,, et al. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer, 2001, 91(11): 2026-2032.
|
| 9 |
Tannapfel A, Neid M, Aust D, et al. The origins of colorectal carcinoma: specific nomenclature for different pathways and precursor lesions.. Dtsch Arztebl Int, 2010, 107(43): 760-766.
|
| 10 |
Liu B, Han M, Wen JK, et al. Livin/ML-IAP as a new target for cancer treatment. Cancer Letter, 2007, 250(2): 168-176.
|
| 11 |
Choi J, Hwang YK, Sung KW, et al. Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia. Blood, 2007, 109(2): 471-477.
|
| 12 |
郭冬梅, 王淑秋, 崔新刚. Livin基因在结直肠癌的表达及其与PTEN、β-Catenin的相关性研究. 牡丹江医学院学报, 2009, 30(2): 9-11.
|
| 13 |
Vucic D, Stennicke HR, Pisabarro MT, et al. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol, 2000, 10(21): 1359-1366.
|